Bladder cancer treatment involving determination of tumor...

Details Bladder cancer treatment involving determination of tumor... Bladder cancer treatment involving determination of tumor...

A - Human Necessities

61

K

A61K 31/404 (2006.01)

Patent

CA 2641617

Disclosed herein are various bladder cancer treatments and methods. The present disclosure can take advantage of propylene glycol concentrations and/or NAD(P)H:quinone oxidoreductase-1 (NQO1 ), Cytochrome P450 Oxidoreductase (P450R) and Glucose transporter 1 (Glut-1 ) protein expression in human transitional cell carcinoma of the bladder to offer individually targeted bladder cancer treatments.

La présente invention concerne divers traitements et procédés du cancer de la vessie. La communication présente peut tirer partie de concentrations de glycol de propylène et/ou de NAD(P)H:quinone oxidoréductase-1 (NQO1 ), Cytochrome P450 Oxidoréductase (P450R) et du transporteur 1 de glucose (Glut-1 ) expression protéine dans le carcinome de cellule transitoire humaine de la vessie pour offrir des traitements du cancer de la vessie individuellement ciblés.

Affiliated with

Also associated with

Rating

Bladder cancer treatment involving determination of tumor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bladder cancer treatment involving determination of tumor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bladder cancer treatment involving determination of tumor... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1570078